163 related articles for article (PubMed ID: 10408695)
1. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).
Degorce F; Goumon Y; Jacquemart L; Vidaud C; Bellanger L; Pons-Anicet D; Seguin P; Metz-Boutigue MH; Aunis D
Br J Cancer; 1999 Jan; 79(1):65-71. PubMed ID: 10408695
[TBL] [Abstract][Full Text] [Related]
2. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
Gill BM; Barbosa JA; Hogue-Angeletti R; Varki N; O'Connor DT
Neuropeptides; 1992 Feb; 21(2):105-18. PubMed ID: 1372966
[TBL] [Abstract][Full Text] [Related]
4. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
5. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
[TBL] [Abstract][Full Text] [Related]
7. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.
Colombo B; Longhi R; Marinzi C; Magni F; Cattaneo A; Yoo SH; Curnis F; Corti A
J Biol Chem; 2002 Nov; 277(48):45911-9. PubMed ID: 12297497
[TBL] [Abstract][Full Text] [Related]
9. Selective processing of chromogranin A in the different islet cells in human pancreas.
Portela-Gomes GM; Stridsberg M
J Histochem Cytochem; 2001 Apr; 49(4):483-90. PubMed ID: 11259451
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
Stridsberg M; Angeletti RH; Helle KB
J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A peptide-specific antisera and high-performance size exclusion chromatography demonstrate amino-terminal and carboxy-terminal fragments of the native molecule in human cell lines.
Brandt DW; Burton DW; Hogue-Angeletti R; Deftos LJ
Proc Soc Exp Biol Med; 1994 Apr; 205(4):316-20. PubMed ID: 8171054
[TBL] [Abstract][Full Text] [Related]
12. Assessment of chromogranin A using two-site immunoassay. Selection of a monoclonal antibody pair unaffected by human chromogranin A processing.
Degorce F
Adv Exp Med Biol; 2000; 482():339-50. PubMed ID: 11192594
[No Abstract] [Full Text] [Related]
13. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.
Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A
FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634
[TBL] [Abstract][Full Text] [Related]
14. A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.
Stridsberg M; Eriksson B; Oberg K; Janson ET
Regul Pept; 2004 Mar; 117(3):219-27. PubMed ID: 14749043
[TBL] [Abstract][Full Text] [Related]
15. Library of sequence-specific radioimmunoassays for human chromogranin A.
Jensen TB; Hilsted L; Rehfeld JF
Clin Chem; 1999 Apr; 45(4):549-60. PubMed ID: 10102916
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A: its clinical value as marker of neuroendocrine tumours.
Nobels FR; Kwekkeboom DJ; Bouillon R; Lamberts SW
Eur J Clin Invest; 1998 Jun; 28(6):431-40. PubMed ID: 9693933
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
[TBL] [Abstract][Full Text] [Related]
18. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung.
Portela-Gomes GM; Grimelius L; Stridsberg M; Bresaola E; Viale G; Pelosi G
Virchows Arch; 2005 Jun; 446(6):604-12. PubMed ID: 15906087
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay for chromogranin A.
Dillen L; De Block J; Van Lear L; De Potter W
Clin Chem; 1989 Sep; 35(9):1934-8. PubMed ID: 2776319
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors.
Ferrari L; Seregni E; Lucignani G; Bajetta E; Martinetti A; Aliberti G; Pallotti F; Procopio G; Della Torre S; Luksch R; Bombardieri E
Int J Biol Markers; 2004; 19(4):295-304. PubMed ID: 15646836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
